CD34 and acute myeloid leukemia: We overlaid those USP7 peaks with non-canonical PRC1.1 peaks and canonical PRC1 peaks that we identified in our previous study in a cohort of six primary AML CD34+ patient samples (van den Boom et al., 2016).